UniProt ID | MTG16_HUMAN | |
---|---|---|
UniProt AC | O75081 | |
Protein Name | Protein CBFA2T3 | |
Gene Name | CBFA2T3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 653 | |
Subcellular Localization |
Isoform 1: Nucleus, nucleolus. The RUNX1-CBFA2T3 fusion protein localizes to the nucleoplasm. Isoform 2: Nucleus, nucleoplasm . Golgi apparatus membrane . |
|
Protein Description | Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes. [PubMed: 12559562] | |
Protein Sequence | MPASRLRDRAASSASGSTCGSMSQTHPVLESGLLASAGCSAPRGPRKGGPAPVDRKAKASAMPDSPAEVKTQPRSTPPSMPPPPPAASQGATRPPSFTPHTHREDGPATLPHGRFHGCLKWSMVCLLMNGSSHSPTAINGAPCTPNGFSNGPATSSTASLSTQHLPPACGARQLSKLKRFLTTLQQFGSDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPFVIPFLKANLPLLQRELLHCARLAKQTPAQYLAQHEQLLLDASASSPIDSSELLLEVNENGKRRTPDRTKENGSDRDPLHPEHLSKRPCTLNPAQRYSPSNGPPQPTPPPHYRLEDIAMAHHFRDAYRHPDPRELRERHRPLVVPGSRQEEVIDHKLTEREWAEEWKHLNNLLNCIMDMVEKTRRSLTVLRRCQEADREELNHWARRYSDAEDTKKGPAPAAARPRSSSAGPEGPQLDVPREFLPRTLTGYVPEDIWRKAEEAVNEVKRQAMSELQKAVSDAERKAHELITTERAKMERALAEAKRQASEDALTVINQQEDSSESCWNCGRKASETCSGCNAARYCGSFCQHRDWEKHHHVCGQSLQGPTAVVADPVPGPPEAAHSLGPSLPVGAASPSEAGSAGPSRPGSPSPPGPLDTVPR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | RLRDRAASSASGSTC HHHHHHHHCCCCCCC | 26.00 | 30576142 | |
15 | Phosphorylation | DRAASSASGSTCGSM HHHHHCCCCCCCCCC | 34.91 | - | |
25 | Phosphorylation | TCGSMSQTHPVLESG CCCCCCCCCCHHHHC | 22.35 | 30576142 | |
36 | Phosphorylation | LESGLLASAGCSAPR HHHCHHHHCCCCCCC | 25.76 | 30576142 | |
40 | Phosphorylation | LLASAGCSAPRGPRK HHHHCCCCCCCCCCC | 40.15 | 26434552 | |
47 | Methylation | SAPRGPRKGGPAPVD CCCCCCCCCCCCCCC | 71.94 | - | |
65 | Phosphorylation | KASAMPDSPAEVKTQ HHHCCCCCCHHHCCC | 21.82 | 23401153 | |
70 | Ubiquitination | PDSPAEVKTQPRSTP CCCCHHHCCCCCCCC | 32.71 | - | |
75 | Phosphorylation | EVKTQPRSTPPSMPP HHCCCCCCCCCCCCC | 52.53 | 23401153 | |
76 | Phosphorylation | VKTQPRSTPPSMPPP HCCCCCCCCCCCCCC | 40.26 | 23186163 | |
79 | Phosphorylation | QPRSTPPSMPPPPPA CCCCCCCCCCCCCCC | 45.16 | 23186163 | |
88 | Phosphorylation | PPPPPAASQGATRPP CCCCCCCCCCCCCCC | 31.11 | 23186163 | |
244 | Phosphorylation | KANLPLLQRELLHCA HCCCHHHHHHHHHHH | 44.47 | 32142685 | |
300 | Ubiquitination | RRTPDRTKENGSDRD CCCCCCCCCCCCCCC | 50.50 | - | |
320 | Phosphorylation | HLSKRPCTLNPAQRY HHCCCCCCCCHHHCC | 32.05 | 26552605 | |
327 | Phosphorylation | TLNPAQRYSPSNGPP CCCHHHCCCCCCCCC | 16.92 | 28450419 | |
328 | Phosphorylation | LNPAQRYSPSNGPPQ CCHHHCCCCCCCCCC | 24.84 | 23401153 | |
330 | Phosphorylation | PAQRYSPSNGPPQPT HHHCCCCCCCCCCCC | 48.77 | 28464451 | |
337 | Phosphorylation | SNGPPQPTPPPHYRL CCCCCCCCCCCCCCH | 43.08 | 23401153 | |
342 | Phosphorylation | QPTPPPHYRLEDIAM CCCCCCCCCHHHHHH | 23.75 | 30108239 | |
429 | Ubiquitination | RCQEADREELNHWAR HHHHHCHHHHHHHHH | 68.34 | 29967540 | |
439 | Phosphorylation | NHWARRYSDAEDTKK HHHHHHHCCHHHHCC | 28.65 | 24719451 | |
444 | Phosphorylation | RYSDAEDTKKGPAPA HHCCHHHHCCCCCCC | 26.59 | 26074081 | |
449 | Ubiquitination | EDTKKGPAPAAARPR HHHCCCCCCCCCCCC | 18.29 | 17203973 | |
457 | Phosphorylation | PAAARPRSSSAGPEG CCCCCCCCCCCCCCC | 31.18 | 23401153 | |
458 | Phosphorylation | AAARPRSSSAGPEGP CCCCCCCCCCCCCCC | 26.03 | 30278072 | |
459 | Phosphorylation | AARPRSSSAGPEGPQ CCCCCCCCCCCCCCC | 38.19 | 23401153 | |
477 | Phosphorylation | PREFLPRTLTGYVPE CHHHCCCHHCCCCCH | 27.08 | - | |
479 | Phosphorylation | EFLPRTLTGYVPEDI HHCCCHHCCCCCHHH | 26.34 | 23186163 | |
489 | Ubiquitination | VPEDIWRKAEEAVNE CCHHHHHHHHHHHHH | 45.19 | - | |
498 | Ubiquitination | EEAVNEVKRQAMSEL HHHHHHHHHHHHHHH | 32.39 | - | |
510 | Ubiquitination | SELQKAVSDAERKAH HHHHHHHHHHHHHHH | 35.64 | 17203973 | |
515 | Ubiquitination | AVSDAERKAHELITT HHHHHHHHHHHHHHH | 45.67 | 29967540 | |
521 | Phosphorylation | RKAHELITTERAKME HHHHHHHHHHHHHHH | 34.92 | - | |
535 | Ubiquitination | ERALAEAKRQASEDA HHHHHHHHHHHCHHH | 36.23 | 17203973 | |
539 | Phosphorylation | AEAKRQASEDALTVI HHHHHHHCHHHHHHH | 27.89 | 24275569 | |
578 | Phosphorylation | NAARYCGSFCQHRDW CHHHHCCCHHHCCCH | 21.20 | - | |
627 | Phosphorylation | SLPVGAASPSEAGSA CCCCCCCCHHHCCCC | 28.55 | 26074081 | |
629 | Phosphorylation | PVGAASPSEAGSAGP CCCCCCHHHCCCCCC | 37.27 | 26074081 | |
633 | Phosphorylation | ASPSEAGSAGPSRPG CCHHHCCCCCCCCCC | 36.78 | 26074081 | |
637 | Phosphorylation | EAGSAGPSRPGSPSP HCCCCCCCCCCCCCC | 50.63 | 26074081 | |
641 | Phosphorylation | AGPSRPGSPSPPGPL CCCCCCCCCCCCCCC | 25.53 | 26074081 | |
643 | Phosphorylation | PSRPGSPSPPGPLDT CCCCCCCCCCCCCCC | 45.48 | 26074081 | |
650 | Phosphorylation | SPPGPLDTVPR---- CCCCCCCCCCC---- | 39.84 | 11823486 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTG16_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTG16_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTG16_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MTG8_HUMAN | RUNX1T1 | physical | 14703694 | |
MTG8R_HUMAN | CBFA2T2 | physical | 12242670 | |
HDAC1_HUMAN | HDAC1 | physical | 12242670 | |
HDAC3_HUMAN | HDAC3 | physical | 12242670 | |
TAL1_HUMAN | TAL1 | physical | 16407974 | |
TFE2_HUMAN | TCF3 | physical | 16407974 | |
LDB1_HUMAN | LDB1 | physical | 16407974 | |
KAP2_HUMAN | PRKAR2A | physical | 11823486 | |
SIN3B_HUMAN | SIN3B | physical | 18586123 | |
NCOR1_HUMAN | NCOR1 | physical | 18586123 | |
ZBT47_HUMAN | ZBTB47 | physical | 20116376 | |
MATN2_HUMAN | MATN2 | physical | 21988832 | |
GMEB2_HUMAN | GMEB2 | physical | 21988832 | |
SC24A_HUMAN | SEC24A | physical | 21988832 | |
ZBTB4_HUMAN | ZBTB4 | physical | 23251453 | |
ZBT38_HUMAN | ZBTB38 | physical | 23251453 | |
KAISO_HUMAN | ZBTB33 | physical | 23251453 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-337 AND SER-459, ANDMASS SPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"The proteomic reactor facilitates the analysis of affinity-purifiedproteins by mass spectrometry: application for identifyingubiquitinated proteins in human cells."; Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M.,Haines D.S., Figeys D.; J. Proteome Res. 6:298-305(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-535, AND MASSSPECTROMETRY. |